Recursion Pharmaceuticals NASDAQ:RXRX Chief Executive Officer Christopher Gibson sold 100,000 shares of Class A Common Stock on October 23, 2025, at a price of $5.70, totaling $570,000. The sale ...
Big changes to the license used by the popular open source key/value store Redis prompted a fork, with the launch of Valkey. In the time since that fork in March 2024, the two projects have diverged.
Dublin, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The "AI in Biotechnology: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global market for AI in biotechnology was valued at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback